Is TRT a lifelong treatment? It depends on why testosterone is low

Whether TRT is a lifelong treatment is really two questions, because hypogonadism - the medical term for testosterone low enough to cause symptoms - comes in two kinds [13].

The first is permanent damage to the testicles, or to the pituitary gland in the brain that instructs them. That does not repair itself, so replacement is expected to continue indefinitely. The second kind is low testosterone with no damage to find, where obesity, type 2 diabetes or ageing are doing the work, and this is the contested case: treating the underlying cause comes first, with replacement used when that fails [13][15].

Stopping is not simply a matter of skipping the next dose, because testosterone from outside silences the body's own supply while you are on it [7]. The brain reads the incoming hormone as proof there is enough and stops sending the signals that tell the testicles to work, so production inside the testicle falls steeply [7].

The clearest numbers on what happens afterwards come from a study that followed 100 male amateur athletes through a course of high-dose androgens, the hormone family that includes testosterone, and for a year from the start of it [11]. Three months after they stopped, average testosterone was back to where it had been before they started, but about one man in nine still had testosterone below the normal range at the one-year mark [11].

Sperm recovered far more slowly than the hormone did. During the cycle, 77% of the men had a total sperm count below 40 million, the number of sperm in a whole sample; a year after starting, 34% were still under that threshold [11]. Sperm production usually resumes once testosterone is stopped, but how fast varies enough between men to complicate family planning [7].

The trials behind testosterone treatment are also short next to the word lifelong. The largest treated 5,246 men aged 45 to 80 who had low testosterone and either heart disease or a high risk of it, for an average of about 22 months [1]. Improvements in sexual activity, sexual desire and symptoms of low testosterone were still there at 24 months, though erectile function did not improve [2]. What happens in year 15 has not been measured.

Testosterone production runs on a feedback loop between the brain and the testicles. The hypothalamus and the pituitary gland, two structures at the base of the brain, release gonadotropins - hormone messengers that travel to the testicles and tell them to make testosterone and sperm [7].

Testosterone delivered as a gel, a patch or an injection arrives in the blood without any of that signalling. The brain registers enough hormone and turns the messengers down, so the testicles stop making their own [7]. Sperm are hit harder than a blood test suggests, because sperm production needs a testosterone concentration inside the testicle far above the level circulating in blood, and it is that internal supply which collapses [7].

The shutdown builds gradually and so does the recovery. Pharmacological models of injected testosterone have to include both to fit the real data: suppression of a man's own production that deepens the longer treatment runs, then a slow return once it stops [12].

This is also why the cause of the low reading decides the answer. In obesity-related low testosterone the testicles and pituitary are intact and the signalling is being dampened by body fat and the metabolic problems that come with it, so losing weight can lift levels [15]. Where the tissue itself is damaged, there is nothing to restart [13].

The recovery timeline everyone quotes comes from one study of a particular group, and the differences matter:

• The 100 men in it were amateur strength athletes taking supraphysiological doses, meaning amounts well above anything the body makes on its own, by choice rather than on prescription [11].
• Follow-up ran a single year, which the authors call short given how long sperm production takes to come back [11].
• Recovery was not universal even there. Some men still had low testosterone and low sperm counts at the end, and those with heavier past exposure to androgens appear to be most at risk [11].

The large safety trials have their own boundaries. Their participants were men aged 45 to 80 with low testosterone and existing heart disease or a high risk of it, treated for around two years [1][3]. Those results do not automatically transfer to a healthy 30-year-old, and two years of data cannot answer a question about decades.

For low testosterone caused by past anabolic steroid use, the evidence is thin. A review that set out to be a meta-analysis found no studies of adequate quality to include, so its guidance rests on published reports and expert opinion [6].

None of this applies to women. Hormone therapy after premature ovarian insufficiency, where the ovaries stop working early, is a separate body of evidence with its own guideline [5].

A man in his late thirties who turns up with low testosterone, weight gain and low libido is the case the guidelines argue about most [13]. If nothing is wrong with his testicles or pituitary, the first move is the cause rather than the hormone, though the reviews are blunt that few people manage enough weight loss through lifestyle change alone, which is why replacement often gets started anyway [15]. Fertility is the part most easily missed at that first appointment: testosterone taken from outside the body is contraindicated in men trying to conceive, meaning it should not be used while they are, and where sperm production has to be protected or rebuilt, clinicians use medicines that work through the body's own signalling instead, including gonadotropins and drugs that block oestrogen's feedback on the brain [7][6]. That conversation is easier to have before the first prescription than after.